The Food and Drug Administration has approved a migraine drug from New Haven-based company Biohaven.

Nurtec is the first and only migraine medication for acute and preventative treatment.

In a clinical trial, the drug reduced migraine days by 30% after around a week of patients taking it every other day.

Patients saw a 50% reduction a few months following taking the medicine.